Eric Logigian, M.D.

Current Titles and Roles

Professor of Neurology; Unit Chief, Neuromuscular Disease Unit; Director of EMG Laboratory, University of Rochester Medical Center; Director, Clinical Neurophysiology Residency

Degrees, Certifications, and Licenses

  • B.A., Cornell University, 1971
  • M.D., Boston University School of Medicine, 1978
  • Residency, Internal Medicine, Beth Israel Hospital, 1981; Neurology, Massachusetts General Hospital, 1984
  • Fellowship, Clinical Neurophysiology, Massachusetts General Hospital
  • Certificates, American Board of Neurology, Subspecialty Certification in Clinical Neurophysiology, American Board of Electrodiagnostic Medicine, American Board of Internal Medicine

Prior Work History

  • 1992, Physician (neurology), Brigham and Women’s Hospital, Boston
  • 1998, Attending neurologist, University of Rochester Medical Center, Rochester, New York
  • 1998, Director, EMG Laboratory, University of Rochester Medical Center, Rochester, New York
  • 1998, Director, Clinical Neurophysiology Residency, University of Rochester Medical Center, Rochester, New York
  • 2001, Chief, Neuromuscular Disease Unit, Strong Memorial Hospital, Rochester, New York

Clinical Specialties

Electromyography of neuromuscular diseases, peripheral neuropathy, botulinum toxin therapy of dystonia


Professional memberships:

  • American Neurological Association
  • Fellow, American College of Physicians
  • Fellow, American Academy of Neurology
  • American Association of Electrodiagnostic Medicine


  • Clinical and electrophysiologic aspects of various neuropathies, particularly peripheral nerve disease
  • Physiology and treatment of myotonic myopathy
  • Neurological aspects of Lyme disease
  • The application of clinical neurophysiology to aspects of human motor control in health and disease

Academic Activity

Dr. Logigian is responsible for teaching neurology residents and neurophysiology fellows as they rotate through the EMG laboratory.


Dr. Logigian specializes in the diagnosis and treatment of patients with neuromuscular disorders in general, but particularly of patients with peripheral neuropathy.


Scroll to Top